Pituitary Tumor Suppression by Combination of Cabergoline and Chloroquine

Abstract

The data suggest that combined use of CAB and CQ may increase clinical effectiveness in treatment of human pituitary adenomas, as well as other cancers, making it an attractive option in tumor and cancer therapies.